Loading page
Loading page
Loading substance route
Higher doses substantially increase risk of amnestic episodes. Approximately 10 times more potent than diazepam by weight.
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Delorazepam is classified as habit-forming with recognized abuse potential. Patients with a history of substance or alcohol use are believed to have an increased risk of abuse. Non-medical use in prescribed patients has been documented and generally develops slowly, becoming evident only after months or years of therapy.
Physical dependence is the most serious effect of long-term use, with withdrawal symptoms that mimic delirium tremens. Although withdrawal effects are generally less severe than shorter-acting benzodiazepines, they can be life-threatening. Slow tapering over weeks or months is recommended to minimize withdrawal severity. Psychological effects such as rebound anxiety and insomnia may persist for months after physical dependence has been treated.
Overdoses of benzodiazepines alone rarely result in death. However, combination with other sedatives, particularly other GABAergic drugs such as barbiturates and alcohol, is far more likely to result in fatal outcomes.
Long-term use has been associated with cognitive deficits that may persist longer than six months, with some researchers suggesting these effects could be permanent; short-term use carries minimal risk of lasting cognitive impairment.
Paradoxical reactions including increased anxiety, excitation, aggression, and hallucinations may occur but are uncommon. These reactions are more frequent in elderly, pediatric, and schizophrenic patients. In rare instances, delorazepam may cause suicidal ideation and actions. Contraindicated in patients with severe schizophrenia or schizo-affective disorders.
Delorazepam is an uncommon benzodiazepine that has been marketed primarily in Italy, where it is available under the trade name EN. The compound is notable for its relationship to other benzodiazepines in this class, serving as an active metabolite of both diclazepam and cloxazolam. As a derivative…
9 sources cited
